From: Obesity attenuates gender differences in cardiovascular mortality
 | BMI, kg/m2 | WC, cm* | WHR* | WHtR* | ||||||
---|---|---|---|---|---|---|---|---|---|---|
<25.0 | 25.0-29.9 | 30.0-34.9 | ≥35.0 | <90 (F)/99 (M) | ≥90 (F)/99 (M) | <0.85 (F)/0.97 (M) | ≥0.85 (F)/0.97 (M) | <0.56 (F)/0.57 (M) | ≥0.56 (F)/0.57 (M) | |
Non-diabetic (n = 17 056) |  |  |  |  |  |  |  |  |  | |
Mortality rate (95% CI) | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Women | 9 (6-13) | 14 (10-19) | 29 (20-41) | 50 (30-76) | 12 (9-15) | 29 (22-39) | 14 (11-17) | 24 (17-32) | 11 (9-14) | 32 (24-41) |
Men | 26 (21-32) | 41 (35-48) | 57 (44-73) | 45 (18-92) | 30 (26-34) | 59 (50-71) | 31 (27-35) | 60 (49-71) | 28 (24-33) | 66 (56-78) |
Sex ratio in CVD mortality rate (M/F) | 2.9 | 3.0 | 2.0 | 0.9 | 2.5 | 2.0 | 2.3 | 2.5 | 2.6 | 2.1 |
Hazard ratios (95% CI)†|  |  |  |  |  |  |  |  |  | |
Women | 1.0 (Reference) | 1.0 (0.7-1.6) | 1.8 (1.1-3.0) | 3.3 (1.9-5.8) | 1.0 (Reference) | 1.8 (1.3-2.6) | 1.0 (Reference) | 1.5 (1.0-2.2) | 1.0 (Reference) | 2.0 (1.4-2.8) |
Men | 3.6 (2.4-5.4) | 3.9 (2.7-5.7) | 4.6 (3.0-7.0) | 4.1 (1.8-9.4) | 3.3 (2.5-4.3) | 4.4 (3.3-5.8) | 3.0 (2.3-3.8) | 4.1 (3.1-5.4) | 3.3 (2.5-4.4) | 4.7 (3.5-6.3) |
Sex ratio in CVD mortality risk (M/F) | 3.6 (2.4-5.4) | 3.7 (2.7-5.3) | 2.5 (1.6-3.8) | 1.3 (0.5-3.0) | 3.3 (2.5-4.3) | 2.4 (1.7-3.3) | 3.0 (2.3-3.8) | 2.7 (1.9-3.9) | 3.3 (2.5-4.4) | 2.4 (1.8-3.3) |
Hazard ratios (95% CI)†|  |  |  |  |  |  |  |  |  | |
Women | 1.0 (Reference) | 1.1 (0.7-1.7) | 1.9 (1.2-3.0) | 3.3 (1.9-5.8) | 1.0 (Reference) | 1.9 (1.4-2.8) | 1.0 (Reference) | 1.8 (1.2-2.6) | 1.0 (Reference) | 2.0 (1.4-2.9) |
Men | 3.2 (2.1-4.8) | 3.4 (2.3-4.9) | 3.9 (2.5-6.0) | 3.8 (1.7-8.6) | 2.9 (2.2-3.8) | 3.8 (2.8-5.1) | 2.6 (2.0-3.3) | 4.1 (3.1-5.6) | 2.9 (2.2-3.9) | 4.0 (2.9-5.4) |
Sex ratio in CVD mortality risk (M/F) | 3.2 (2.1-4.8) | 3.1 (2.2-4.4) | 2.1 (1.4-3.2) | 1.2 (0.5-2.7) | 2.9 (2.2-3.8) | 2.0 (1.4-2.7) | 2.6 (2.0-3.3) | 2.3 (1.6-3.3) | 2.9 (2.2-3.9) | 2.0 (1.4-2.7) |
Diabetic (n = 4499) |  |  |  |  |  |  |  |  |  | |
Mortality rate (95% CI) | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Women | 39 (22-63) | 52 (36-74) | 57 (37-84) | 70 (43-407) | 40 (28-57) | 64 (49-83) | 37 (26-51) | 73 (55-94) | 35 (23-51) | 66 (51-83) |
Men | 54 (36-77) | 118 (95-144) | 138 (103-182) | 146 (80-245) | 80 (64-99) | 138 (113-167) | 89 (72-108) | 130 (105-160) | 84 (67-105) | 128 (105-154) |
Sex ratio in CVD mortality rate (M/F) | 1.4 | 2.3 | 2.4 | 2.1 | 2.0 | 2.1 | 2.4 | 1.8 | 2.4 | 1.9 |
Hazard ratios (95% CI)†|  |  |  |  |  |  |  |  |  | |
Women | 1.0 (Reference) | 1.0 (0.6-1.9) | 1.0 (0.5-1.8) | 1.3 (0.7-2.5) | 1.0 (Reference) | 1.1 (0.7-1.7) | 1.0 (Reference) | 1.3 (0.8-1.9) | 1.0 (Reference) | 1.2 (0.8-1.9) |
Men | 1.3 (0.7-2.3) | 2.2 (1.3-3.8) | 2.5 (1.4-4.4) | 2.7 (1.3-5.7) | 1.8 (1.2-2.7) | 2.4 (1.6-3.5) | 2.2 (1.5-3.2) | 2.4 (1.6-3.6) | 2.2 (1.4-3.4) | 2.3 (1.5-3.6) |
Sex ratio in CVD mortality risk (M/F) | 1.3 (0.7-2.3) | 2.2 (1.5-3.3) | 2.6 (1.6-4.1) | 2.1 (1.1-4.2) | 1.8 (1.2-2.7) | 2.2 (1.6-3.0) | 2.2 (1.5-3.2) | 1.9 (1.4-2.7) | 2.2 (1.4-3.4) | 1.9 (1.4-2.6) |
Hazard ratios (95% CI)†|  |  |  |  |  |  |  |  |  | |
Women | 1.0 (Reference) | 1.0 (0.5-1.8) | 0.9 (0.5-1.7) | 1.0 (0.5-1.9) | 1.0 (Reference) | 1.2 (0.8-1.8) | 1.0 (Reference) | 1.3 (0.9-2.0) | 1.0 (Reference) | 1.3 (0.8-2.1) |
Men | 1.3 (0.7-2.4) | 1.9 (1.1-3.2) | 1.9 (1.1-3.5) | 1.6 (0.8-3.4) | 1.9 (1.2-2.9) | 2.1 (1.4-3.2) | 2.1 (1.4-3.2) | 2.3 (1.5-3.5) | 2.2 (1.4-3.6) | 2.3 (1.4-3.6) |
Sex ratio in CVD mortality risk (M/F) | 1.3 (0.7-2.4) | 1.9 (1.3-2.9) | 2.2 (1.3-3.6) | 1.7 (0.9-3.4) | 1.9 (1.2-2.9) | 1.8 (1.3-2.6) | 2.1 (1.4-3.2) | 1.7 (1.2-2.4) | 2.2 (1.4-3.6) | 1.7 (1.2-2.4) |